BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 8, 2003
View Archived Issues
Role for NMDA receptor antagonists in pain
Read More
New data on sertraline in GAD, panic disorder and postpartum depression
Read More
Potential use of SM-31900 for treating acute brain ischemia
Read More
Pharmacokinetics of HBOC-201 in surgical patients
Read More
Effects of etiprednol dicloacetate on the HPA axis
Read More
Stiripentol added to carbamazepine effective in refractory partial epilepsy
Read More
CVT-3146: tolerability and pharmacokinetics in man
Read More
Histone deacetylase inhibitors derived from SAHA presented at ACS meeting
Read More
New PTP1B inhibitors in early development at Abbott
Read More
Aventis presents four related series of anorectic compounds
Read More
Novel N-type calcium channel antagonists prepared and tested at Ajinomoto
Read More
Nonsteroidal metal chelators with affinity for steroid receptors for cancer diagnosis and treatment
Read More
Nippon Chemiphar claims PPARdelta agonists with utility in metabolic disorders
Read More
Hepavir B enters clinical testing
Read More
Periostat approved in Canada
Read More
Renagel receives NHI drug price listing in Japan
Read More
Celmed focuses development activities on Theralux and Neuro technology platforms
Read More
Postmarketing Visicol study begins patient treatment
Read More
APT-070 enters phase IIa trials
Read More
Prous Science announces publication of state-of-the-art review: acne vulgaris
Read More
DA-8159 is well tolerated in healthy volunteers and without significant hemodynamic effects
Read More
Thirty-five new products reach their first markets in 2002
Read More
Potent CCR3 receptor antagonists with potential in chronic inflammation
Read More
Merck reports the identification of a surprisingly potent and selective thrombin inhibitor
Read More
Thienopyridines targeting VEGFR tyrosine kinase presented by Pfizer
Read More
Safety, tolerability and pharmacokinetics of single and multiple oral doses of LY-450108
Read More